Back to results
CompletedPhase 1

Effect of Renal Impairment on the Pharmacokinetics of NN9535

NCT00833716

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novo Nordisk Investigational Site

Miami, Florida, United States

+2 additional locations

View on ClinicalTrials.gov
Effect of Renal Impairment on the Pharmacokinetics of NN9535 — TrialFind